Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli

References

1. Appelmelk B. J., VughtA M. J. J., MacLaren D. M., Thijs L. G. 1985; An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the Gram-negative lipopolysaccharide core region. Journal of Immunological Methods 82:199–207
   [Google Scholar]
2. Bogard W. C., Abemethy K., Dunn D. L., Kung P. C. 1984; Murine monoclonal antibodies against gram-negative bacterial core-glycolipid: criteria for cross-genera reactivity. Federation Proceedings 43:1682 abstract 1553
   [Google Scholar]
3. Bruins S. C., Stumacher R., Johns M. A., McCabe W. R. 1977; Immunization with R mutants of Salmonella minnesota III. Comparison of the protective effect of immunization with Lipid A and the Re mutant. Infection and Immunity 17:16–20
   [Google Scholar]
4. DeHaan P., DeJonge A. J. R., Verbrugge T., Boorsma D. M. 1985; Three epitope-specific monoclonal antibodies against the hapten penicillin. International Archives of Allergy and Applied Immunology 76:42–46
   [Google Scholar]
5. Dunn D. L., Mach P. A., Cerra F. B. 1983; Monoclonal antibodies protect against lethal effects of Gram-negative bacterial sepsis. Surgical Forum 44:142–143
   [Google Scholar]
6. Dunn D. L., Bogard W. C., Cerra F. B. 1985; Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Surgery 98:283–290
   [Google Scholar]
7. Dunn D. L., Ewald D. C., Chandan N., Cerra F. B. 1986; Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. Archives of Surgery 121:58–62
   [Google Scholar]
8. Elkins K., Metcalf E. S. 1985; Binding activity of a murine antiLipid A monoclonal antibody. Infection and Immunity 48:597–600
   [Google Scholar]
9. Finney D. J. 1971; Statistical method in biological assay. 2nd edn Griffin; London: p 524
   [Google Scholar]
10. Galanos C., Luderitz O., Westphal O. 1971; Preparation and properties of antisera against the Lipid A component of bacterial lipopolysaccharides. European Journal of Biochemistry 24:116–122
    [Google Scholar]
11. Galanos C. 1984; Immunogenic properties of Lipid A. Reviews of Infectious Diseases 6:546–552
    [Google Scholar]
12. Gigliotti F., Shenep J. L. 1985; Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. Journal of Infectious Diseases 151:1005–1011
    [Google Scholar]
13. Johns M., Skehill A., McCabe W. R. 1983; Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. Journal of Infectious Diseases 147:57–67
    [Google Scholar]
14. Kasai N. 1985; In-vitro antigenic reactivity of synthetic Lipid A analogues as determined by monoclonal and conventional antibodies. Biochemical and Biophysical Research Communications 128:607–612
    [Google Scholar]
15. Marks M. I., Ziegler E. J., Douglas H., Corbeil L. B., Braude A. I. 1982; Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Journal of Clinical Investigation 69:742–749
    [Google Scholar]
16. Miner K. M. 1986; Characterization of murine monoclonal antibodies to Echerichia coli J5. Infection and Immunity 52:56–62
    [Google Scholar]
17. Mullan N. A., Newsome P. M., Cunnington P. G., Palmer G. H., Wilson M. E. 1974; Protection against gram-negative infections with antiserum to Lipid A from Salmonella minnesota R595. Infection and Immunity 10:1195–1201
    [Google Scholar]
18. Mutharia L. M., Crockford G., Bogard W. C., Hancock R. E. W. 1984; Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species. Infection and Immunity 45:631–636
    [Google Scholar]
19. Nelles M. J., Niswander C. A. 1984; Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infection and Immunity 46:677–681
    [Google Scholar]
20. Perlmutter R. M., Hansburg D., Briles D. E., Nicolotti R. A., Davie J. M. 1978; Subclass restriction of murine anti-carbohydrate antibodies. Journal of Immunology 121:566–572
    [Google Scholar]
21. Peter G., Chemow M., Keating M. H., Ryff J. C., Zinner S. H. 1982; Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia. Infection 10:228–232
    [Google Scholar]
22. Raubitschek A. A., Pollack M., Larrick J. W. 1985; Preparation of human monoclonal antibodies (mAbs) that react with the conserved core region of endotoxin (LPS). Clinical Research 33:416 A
    [Google Scholar]
23. Rietschel E. T., Galanos C. 1977; Lipid antiserum-mediated protection against lipopolysaccharide- and Lipid A-induced fever and skin necrosis. Infection and Immunity 15:34–49
    [Google Scholar]
24. Telzak E. E., Wolff S. M. 1985; Immunotherapy and immunoprophylaxis of Gram-negative rod bacteremia. In Root R. K., Sande M. A. (eds) Septic shock. Churchill Livingstone; New York: pp 257–276
    [Google Scholar]
25. Teng N. N. H. 1985; Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proceedings of the National Academy of Sciences of the USA 82:1790–1794
    [Google Scholar]
26. Vel Namavar F., VughtA M. J. J., Pubben A. N. B., MacLaren D. M. 1985; Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis. Journal of Clinical Pathology 38:86–91
    [Google Scholar]
27. Verweij-van VughtA M. J. J., den Bosch J. F., Namavar F., Sparrius M., MacLaren D. M. 1983; K antigens of Escherichia coli and virulence in urinary tract infection: studies in a mouse model. Journal of Medical Microbiology 16:147–155
    [Google Scholar]
28. Young L. S. 1984; Monoclonal antibodies: technology and application to gram-negative infections. Infection 12:303–308
    [Google Scholar]
29. Ziegler E. J. 1982; Treatment of gram-negative bacteremia and shock with human antiserum to a mutant of Escherichia coli. New England Journal of Medicine 307:1225–1230
    [Google Scholar]
30. Zierdt C. H. 1982; Blood-lysing solution nontoxic to pathogenic bacteria. Journal of Clinical Microbiology 15:172–174
    [Google Scholar]
31. Zinner S. H., Peter G. 1983; The potential role of cell wall core glycolipids in the immunoprophylaxis and immunotherapy of gram-negative rod bacteriaemia. In Easmon C. S. F., Jeljaszewicz J. (eds) Medical microbiology vol 2 Immunization against bacterial disease. Academic Press; London: pp 71–85
    [Google Scholar]